Is bleeding after menopause always cancer?

Bleeding after menopause is frightening. The first thought most women have is cancer, and it's not an unreasonable fear. But the short answer to whether postmenopausal bleeding is always cancer is: no. The longer answer is that it still needs to be investigated urgently, because cancer is one of the causes, and ruling it out quickly is exactly the point.

What counts as postmenopausal bleeding?

Menopause is confirmed when a woman has gone 12 consecutive months without a period. Any vaginal bleeding after that point, including light spotting or discharge that looks pink or brown, is classified as postmenopausal bleeding. It doesn't matter how minor it seems. One spot on underwear counts.

That definition matters because it sets the threshold low on purpose. The medical guidance is clear: any bleeding after menopause should be assessed by a doctor within a few weeks, not monitored at home to see if it continues.

What actually causes postmenopausal bleeding?

Cancer is responsible for roughly 10 percent of postmenopausal bleeding cases. That figure comes from large gynaecological studies. It means 90 percent of cases have a benign cause. That's reassuring context, not a reason to delay a check.

The most common causes include:

• Vaginal atrophy (genitourinary syndrome of menopause): The vaginal walls thin as oestrogen falls, making them fragile and prone to small tears or bleeding, especially after sex.
• Endometrial atrophy: The uterine lining also thins, and thin tissue can break down and bleed without any underlying disease.
• Uterine polyps: Small, non-cancerous growths on the uterine lining that bleed intermittently.
• Fibroids: Less common after menopause but still present in women who enter menopause with existing fibroids.
• Endometrial hyperplasia: An overgrowth of the uterine lining that can, in some forms, progress to cancer if left untreated.
• Hormone therapy: Some types of HRT, particularly sequential combined therapy, can cause withdrawal bleeds. Breakthrough bleeding in the first few months of HRT is also common.

The serious causes, beyond endometrial cancer, include cervical cancer and, less frequently, ovarian or vaginal cancer. These are rare but real, and they're the reason no episode of postmenopausal bleeding should be dismissed as insignificant.

Endometrial cancer: what raises the risk

Endometrial cancer, which starts in the lining of the uterus, is the most common gynaecological cancer in Australia. It's also one of the most detectable early, precisely because postmenopausal bleeding is an early symptom in most cases.

Factors that raise the risk include obesity, type 2 diabetes, never having been pregnant, late menopause (after age 55), polycystic ovarian syndrome, and a family history of Lynch syndrome or endometrial cancer. Women taking tamoxifen for breast cancer treatment also carry a higher risk. None of these factors make bleeding inevitable, but they give doctors useful context when assessing a patient.

It's worth understanding the difference between risk factors and certainty. A woman with none of those risk factors can still develop endometrial cancer. A woman with all of them may not. The bleeding itself is the signal, not the risk profile.

If you're already thinking about how hormones fit into the picture, the evidence on HRT for menopause is relevant here: certain types of hormone therapy (oestrogen-only HRT in women who still have a uterus) can increase the risk of endometrial hyperplasia, which is why combined HRT is prescribed instead.

What happens when you see a doctor

A GP will typically start with a pelvic examination and a transvaginal ultrasound. The ultrasound measures the thickness of the endometrium (uterine lining). A thickness above 4 millimetres in a postmenopausal woman who isn't on HRT usually warrants further investigation.

If the lining looks thickened or abnormal, the next step is an endometrial biopsy. This is an office procedure that takes a small sample of tissue from the uterine lining for analysis. It's uncomfortable but usually quick. Some women are also referred for a hysteroscopy, where a thin camera is passed into the uterus to look directly at the lining.

The investigation process is well-established and moves quickly when postmenopausal bleeding is reported promptly. In Australia, most women presenting with this symptom are seen within the public or private gynaecological system within a few weeks. The sooner you go, the sooner you know.

Why some women delay, and why it matters

Studies consistently find that women wait an average of 3 to 6 months before presenting with postmenopausal bleeding. The reasons include embarrassment, fear of what the answer might be, uncertainty about whether the symptom was "significant enough," and a belief that it would resolve on its own.

It won't resolve on its own. And for the minority of women whose bleeding is caused by early-stage endometrial cancer, that delay narrows the treatment window. Endometrial cancer caught at stage 1 has a 5-year survival rate above 90 percent in Australian data. Caught at stage 3 or 4, that figure drops sharply.

The other side of this is equally worth saying: most women who present promptly are told the cause is benign, treated, and go home without a cancer diagnosis. But they couldn't have known that without the investigation.

For broader context on what to expect after menopause, the post menopause symptoms guide covers the range of physical changes that are genuinely expected, which helps put bleeding in perspective as something that falls clearly outside the normal range.

What to do right now

Book a GP appointment today. Don't wait to see if it happens again. Tell the receptionist why you're calling so the appointment is prioritised appropriately. Bring a note of when the bleeding occurred, how much, and what colour it was.

If you've been avoiding this conversation because you're not sure your symptoms are "bad enough," that's the fear talking. Postmenopausal bleeding is always worth reporting. The investigation is straightforward, the most likely outcome is reassurance, and the alternative to checking is not knowing.

Australia's official guidance from bodies including the Royal Australian and New Zealand College of Obstetricians and Gynaecologists is unambiguous: all postmenopausal bleeding requires investigation to exclude endometrial cancer. That's not alarmist. That's the standard of care.